45results about How to "Inhibit gastric acid secretion" patented technology

The present invention is related to oral compositions comprising an irreversible gastric H+ / K+-ATPase proton pump inhibitor (PPI) as a gastric acid secretion inhibitor and succinc acid as a parietal cell activator in the gastric lumen. The compositions of the present invention are capable of enhancing the anti-acid activity of PPI in the stomach. The present invention further relates to a method of using such compositions to reduce gastric acid secretion in a mammal.

The present invention provides a compound having a superior acid secretion inhibitory effect and showing an antiulcer activity and the like. The present invention provides a compound represented by the formula (I)wherein R1 is a nitrogen-containing monocyclic heterocyclic group optionally condensed with a benzene ring or a heterocycle, the nitrogen-containing monocyclic heterocyclic group optionally condensed with a benzene ring or a heterocycle optionally has substituent(s), R2 is an optionally substituted C6-14 aryl group, an optionally substituted thienyl group or an optionally substituted pyridyl group, R3 and R4 are each a hydrogen atom, or one of R3 and R4 is a hydrogen atom and the other is an optionally substituted lower alkyl group, an acyl group, a halogen atom, a cyano group or a nitro group, and R5 is an alkyl group or a salt thereof.

O-medium alkyl esters of diflunisal and related compounds are disclosed having anti-platelet activity, hydroxy radical scavenging properties, enhanced hepatic clearance and low ulcerogenic potential. These compounds have general formula (I) wherein n equals 3-13.

Provision of a compound having a superior proton pump action, which shows an antiulcer activity and the like after conversion to an in vivo proton pump inhibitor, a production method thereof and use thereof.A pyrrolo[2,3-c]pyridine compound represented by the formula:wherein each symbol is as defined in the specification.

The invention belongs to the pharmaceutical technical field and specifically relates to imidazopyridine derivatives which are shown in general formula (I) and contain dioxide heterocyclic pyridine, pharmaceutically acceptable salts and isomers thereof, wherein, R<1>, R<2>, R<3> and n are defined as in the specification. The invention also relates to preparation methods of the compounds, drug compositions containing the compounds and the application of the compounds in preparing drugs for preventing and / or treating digestive ulcer.

The invention discloses a functional platycodon grandiflorum tea beverage and a preparation method thereof, relates to a functional tea beverage and a processing method thereof, and aims at solving the technical problems of high time consumption, low efficiency and low content of active ingredients of an existing making method of a platycodon grandiflorum beverage and a single function of the prepared beverage. The functional platycodon grandiflorum tea beverage disclosed by the invention comprises a mixed solution of platycodon grandiflorum clear juice and a scented tea extracting solution, white sugar, citric acid, malic acid, xanthan gum and sodium carboxymethylcellulose. The processing method comprises the following steps: 1, preparing the platycodon grandiflorum clear juice; 2, preparing the scented tea extracting solution; and 3, mixing and blending to obtain the functional platycodon grandiflorum tea beverage. The functional platycodon grandiflorum tea beverage disclosed by the invention is high in content of polysaccharides and flavonoid nutritional substances, is fragrant and sweet as well as cool and delicious, and is a health drink suitable for people of all ages.